736 related articles for article (PubMed ID: 30036646)
1. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
[TBL] [Abstract][Full Text] [Related]
2. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.
Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM
Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928
[TBL] [Abstract][Full Text] [Related]
3. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.
Chen Y; Guo J; Qian G; Fang D; Shi D; Guo L; Li L
J Gastroenterol Hepatol; 2015 Sep; 30(9):1429-37. PubMed ID: 25711972
[TBL] [Abstract][Full Text] [Related]
4. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
[TBL] [Abstract][Full Text] [Related]
5. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis.
Piano S; Tonon M; Vettore E; Stanco M; Pilutti C; Romano A; Mareso S; Gambino C; Brocca A; Sticca A; Fasolato S; Angeli P
J Hepatol; 2017 Dec; 67(6):1177-1184. PubMed ID: 28733221
[TBL] [Abstract][Full Text] [Related]
6. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis.
O'Leary JG; Reddy KR; Garcia-Tsao G; Biggins SW; Wong F; Fallon MB; Subramanian RM; Kamath PS; Thuluvath P; Vargas HE; Maliakkal B; Tandon P; Lai J; Thacker LR; Bajaj JS
Hepatology; 2018 Jun; 67(6):2367-2374. PubMed ID: 29315693
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention.
Halpin AL; de Man TJ; Kraft CS; Perry KA; Chan AW; Lieu S; Mikell J; Limbago BM; McDonald LC
Am J Infect Control; 2016 Jul; 44(7):830-6. PubMed ID: 26905790
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.
Hernaez R; Kramer JR; Liu Y; Tansel A; Natarajan Y; Hussain KB; Ginès P; Solà E; Moreau R; Gerbes A; El-Serag HB; Kanwal F
J Hepatol; 2019 Apr; 70(4):639-647. PubMed ID: 30590100
[TBL] [Abstract][Full Text] [Related]
10. The microbiota in cirrhosis and its role in hepatic decompensation.
Trebicka J; Macnaughtan J; Schnabl B; Shawcross DL; Bajaj JS
J Hepatol; 2021 Jul; 75 Suppl 1(Suppl 1):S67-S81. PubMed ID: 34039493
[TBL] [Abstract][Full Text] [Related]
11. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death.
Xu R; Tan C; Zhu J; Zeng X; Gao X; Wu Q; Chen Q; Wang H; Zhou H; He Y; Pan S; Yin J
Crit Care; 2019 May; 23(1):195. PubMed ID: 31151471
[TBL] [Abstract][Full Text] [Related]
12. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.
Chen T; Yang Z; Choudhury AK; Al Mahtab M; Li J; Chen Y; Tan SS; Han T; Hu J; Hamid SS; Huei LG; Ghazinian H; Nan Y; Chawla YK; Yuen MF; Devarbhavi H; Shukla A; Abbas Z; Sahu M; Dokmeci AK; Lesmana LA; Lesmana CRA; Xin S; Duan Z; Guo W; Ma K; Zhang Z; Cheng Q; Jia J; Sharma BC; Sarin SK; Ning Q
Hepatol Int; 2019 Nov; 13(6):695-705. PubMed ID: 31650510
[TBL] [Abstract][Full Text] [Related]
13. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
[TBL] [Abstract][Full Text] [Related]
15. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
[TBL] [Abstract][Full Text] [Related]
16. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection.
Lopes-Secundo TM; Sevá-Pereira T; Correa BR; Silva NCM; Imbrizi MR; Cunha-Silva M; Soares EC; Almeida JRS
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1055-1059. PubMed ID: 29944488
[TBL] [Abstract][Full Text] [Related]
17. Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience.
O'Leary JG; Bajaj JS; Tandon P; Biggins SW; Wong F; Kamath PS; Garcia-Tsao G; Maliakkal B; Lai J; Fallon M; Vargas HE; Thuluvath P; Subramanian R; Thacker LR; Reddy KR
Liver Transpl; 2019 Apr; 25(4):571-579. PubMed ID: 30724010
[TBL] [Abstract][Full Text] [Related]
18. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
[TBL] [Abstract][Full Text] [Related]
19. Iron deficiency anemia-related gut microbiota dysbiosis in infants and young children: A pilot study.
Muleviciene A; D'Amico F; Turroni S; Candela M; Jankauskiene A
Acta Microbiol Immunol Hung; 2018 Dec; 65(4):551-564. PubMed ID: 30418043
[TBL] [Abstract][Full Text] [Related]
20. Gut Dysbiosis With Bacilli Dominance and Accumulation of Fermentation Products Precedes Late-onset Sepsis in Preterm Infants.
Graspeuntner S; Waschina S; Künzel S; Twisselmann N; Rausch TK; Cloppenborg-Schmidt K; Zimmermann J; Viemann D; Herting E; Göpel W; Baines JF; Kaleta C; Rupp J; Härtel C; Pagel J
Clin Infect Dis; 2019 Jul; 69(2):268-277. PubMed ID: 30329017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
